Yu T, Chae M, Wang Z, Ryu G, Kim GB, Lee SY (2025) Microbial technologies enhanced by artificial intelligence for healthcare applications
You will want to start thinking about how youre going to stick to a healthy diet and exercise regimen while youre using the GLP-1 injections
[1] Chelation therapy has a long history of use in clinical toxicology [2] and remains in use for some very specific medical treatments, although it is administered under very careful medical supervision due to various inherent risks, including the mobilization of mercury and other metals through the brain and other parts of the body by the use of weak chelating agents that unbind with metals before elimination, exacerbating existing damage
Given this wide-ranging protective role, low levels of glutathione have been shown to be incompatible with optimum health
Such success can be attributed to Jens Juul Holst, a professor in the Department of Biomedical Sciences and the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen, who discovered glucagon-like peptide 1 (GLP-1) is a gut hormone contributing to the glucose-induced gastrointestinal stimulation of insulin secretion and thus a potential diabetes drug
What NAPQI does: Directly binds to and damages cellular proteins Depletes glutathione rapidly Generates oxidative stress which damages DNA Triggers cell death Damages mitochondria, disrupting energy production NAPQI crosses the placenta and depletes fetal brain glutathione at doses below those causing maternal liver toxicity